AlloVir, Inc. (ALVR) NASDAQ
9.81
+0.39(+4.14%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.5B |
| Enterprise Value | 1.4B |
| P/E Ratio | -2.5 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.61 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.4 |
| Return On Equity | -0.73 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -46.15M |
| Net Income | -43.44M |
| Diluted EPS | -2.85 |
Balance Sheet
| Total Cash | 97.22M |
| Total Cash/Share | 4.1 |
| Total Debt | 1.41M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 12.14 |
| Book Value Per Share | 2.89 |
Price History
| 52-Week Change | -43.65 |
| 52-Week High | 24.15 |
| 52-Week Low | 7.96 |
| Moving Average 50 Days | 9.73 |
| Moving Average 200 Days | 14.55 |
Statistics
| Average Volume | 22,940 |
| Shares Outstanding | 5.04M |
| % Held by Institutions | 1.43 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:23 |
| Last Split Date | January 16, 2025 |
